Electric zaps to the gut could tame diabetes and fatty liver

NCT ID NCT07390422

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a procedure called pulsENDO that uses mild electric pulses to regenerate the lining of the duodenum (the first part of the small intestine). The goal is to improve blood sugar control and reduce fat buildup in the liver for people with type 2 diabetes and fatty liver disease. The trial will enroll 40 adults who have not achieved good blood sugar control with oral medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pulsENDO procedure (electric pulses to regenerate the duodenum)
What this could lead to
If it works, this could offer a new, non-surgical way to improve blood sugar control and reduce fatty liver in people with type 2 diabetes.
What could go wrong
This is a small, early-stage trial with only 40 people, so results may not apply to everyone. The procedure involves endoscopy and carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chinese University of Hong Kong

    Shatin, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.